VIVIO is a for-profit company and has been since our founding in 2016. We haven’t raised any external capital and have used our profits to fuel R&D and growth. Last year, across our book of business, we reduced our customers’ net spend on specialty drugs by 37%. We’ve also measured our performance internally by how many dollars we’ve extracted from the bloated US healthcare system and put back in the pockets of consumers. We are most proud of the millions of dollars that America avoided spending on overpriced and unnecessary healthcare, allowing our employer customers to invest in their core businesses, save jobs during the pandemic and reduce the amount that their employees paid for healthcare.